The weekly litigation news digest is live. Subscribe now

IP Verse

Use Of Pilocarpine Hydrochloride For The Treatment Of Ocular Conditions - EP3681500

The patent EP3681500 was granted to Allergan on Jul 30, 2025. The application was filed on Apr 24, 2019 under application number EP19729883A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3681500

ALLERGAN
Application Number
EP19729883A
Filing Date
Apr 24, 2019
Status
Patent Maintained As Amended
Jun 27, 2025
Publication Date
Jul 30, 2025
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
TEVA PHARMACEUTICALSDec 20, 2022KRAUS & LEDERER PARTGMBBWITHDRAWN

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS5424078
EXAMINATIONEP1938839
INTERNATIONAL-SEARCH-REPORTEP1938839
INTERNATIONAL-SEARCH-REPORTEP2886113
INTERNATIONAL-SEARCH-REPORTUS2005205101
INTERNATIONAL-SEARCH-REPORTWO0064425
OPPOSITIONWO0006135

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents